Etiocholanolone in the evaluation of marrow reserves in patients receiving cytotoxic agents.
D000328:Adult; D000970:Antineoplastic Agents / Q000494:pharmacology*; D001856:Bone Marrow Examination; D002051:Burkitt Lymphoma / Q000188:drug therapy; D002648:Child; D002822:Choriocarcinoma / Q000188:drug therapy; D004731:Endotoxins; D005043:Etiocholanolone; D005260:Female; D006689:Hodgkin Disease / Q000188:drug therapy; D006801:Humans; D007958:Leukocyte Count; D007962:Leukocytes / Q000187:drug effects*; D008223:Lymphoma / Q000188:drug therapy; D016403:Lymphoma, Large B-Cell, Diffuse / Q000188:drug therapy; D008297:Male; D008875:Middle Aged; D009369:Neoplasms / Q000188:drug therapy*; D011247:Pregnancy
D000970:Antineoplastic Agents; D004731:Endotoxins; D005043:Etiocholanolone